ADHD – methylphenidate — RACP Paediatrics MCQ

Instant feedback + full explanation. One question, done properly.

EasyNeurologyADHD – methylphenidateRACP Paediatrics

A 7-year-old with ADHD (combined presentation) has significant functional impairment at school despite implemented behavioural strategies over 6 months. The family seeks pharmacological treatment. What is the most appropriate first-line medication?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: B — Methylphenidate

Methylphenidate is the first-line pharmacological treatment for ADHD in children aged ≥6 years in Australia. It is a CNS stimulant that increases dopamine and noradrenaline in the prefrontal cortex. Both short-acting (immediate release) and long-acting (modified release) formulations are available. Regular monitoring of height, weight, BP, and heart rate is required.

Reference: Australian Therapeutic Guidelines – 2024 – Psychotropic; RACP Paediatric Curriculum – Neurodevelopment